Jupiter Hospitals Q2 EBITDA Impacted by Dombivli Ramp-up

Average Occupancy Rate: 64% for H1FY27.
Average Revenue Per Occupied Bed (ARPOB): Rs 54,500 for H1FY27.
Inpatient ARPOB: Rs 59,900 for H1FY27.
Average Length of Stay (ALOS): 4.3 days for H1FY27.
Out-patient volume: 477,000 for H1FY27.
Inpatient volume: 39,000 for H1FY27.
Operational beds: 1,200 as of September 30, 2026.
Key drivers: Higher infectious-disease burden at Dombivli hospital drove higher occupancy and narrowed its EBITDA loss to Rs 0.2 crore in Q2FY27 from Rs 9.5 crore in Q1FY27.

Revenue: Rs 1,030.9 crore for H1FY27 (Consolidated).
EBITDA: Rs 202.8 crore for H1FY27 (Consolidated), which includes an operational loss of Rs 9.7 crore from Dombivli Hospital during its initial ramp-up phase.
PAT: Rs 95.8 crore for H1FY27 (Consolidated).
EPS: Rs 14.6 for H1FY27 (Consolidated, restated pursuant to share sub-division).
Margins: Not explicitly stated as a percentage.
YoY/QoQ comparison: H1FY27 Net Profit Before Tax was Rs 125.6 crore vs Rs 136.0 crore in H1FY26.
Drivers of financial performance: Impacted by initial ramp-up losses at Dombivli Hospital of Rs 9.7 crore in H1FY27 along with higher marketing costs related to launch activities; Higher depreciation following commercialisation of Dombivli hospital; Higher finance costs owing to an increase debt drawdown for ongoing capex.
Key Risks: Not explicitly disclosed in the provided data.

Total Equity: Rs 1,630.5 crore.
Non-Current Liabilities: Rs 683.3 crore.
Current Liabilities: Rs 246.3 crore.
Total Assets: Rs 2,560.1 crore.
Non-Current Assets: Rs 1,945.4 crore.
Current Assets: Rs 614.7 crore.
Borrowings (Non-Current + Current): Rs 588.8 crore (Rs 565.5 crore non-current + Rs 23.3 crore current).
Cash and cash equivalents: Rs 45.1 crore.
Financial Health Insights: Net Cash from Operating Activities was Rs 136.1 crore for H1FY27.

Capital Expenditure: Implied through Cash Flow from Investing Activities of Rs -176.3 crore.
Free Cash Flow: Not explicitly stated.
Operating Cash Flow: Net Cash from Operating Activities was Rs 136.1 crore.
Net Debt Movement: Not explicitly disclosed.
Investment Rationale: Ongoing capex for bed capacity expansion.

Investments in Innovation: Board approved the acquisition of 11,452.07 sq. m. of land for the Pune South hospital for a total consideration of Rs 150 crore. A Rs 50 crore deposit paid earlier will be adjusted, limiting incremental cash outflow to Rs 100 crore.
Construction at Pune South is progressing well and remains on schedule.
The Mira Road and BKC projects are currently in the regulatory approval and planning stages.
Strategic Rationale: Owning the land removes long-term lease risk and strengthens the asset base at a key growth location; Strategic land bank in high-demand micro markets; Phased commissioning to optimize capital deployment; Strong operating leverage from consolidated scale.

| Pune II | 500 | 1.2 | CY28 | Under construction |

| Mira-Bhayandar | 300 | 1.3 | CY29 | Project currently at conceptualization and planning stage |

| BKC | 400 | 1.5 | CY31 | Documentation & registration |

Strategic Outlook: From Dr. Ankit Thakker, MD & CEO: "I am pleased to share that, following successful negotiations with the landowner, the Board has approved the acquisition of the land currently leased for our Pune South hospital... Owning the land removes long-term lease risk and strengthens our asset base at one of our key growth locations."
FY Guidance: Not explicitly provided.
Market Share Targets: Not explicitly provided.
Risks and Opportunities: Not explicitly highlighted beyond the forward-looking statement disclaimer included in the presentation.